entity

orexin receptor antagonists

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about orexin receptor antagonists: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2Connections

0Hypotheses

2Analyses

2Outgoing

0Incoming

0Experiments

2Debates

No AI portrait yet

Outgoing (2)

Target	Relation	Type	Str
neurodegeneration	therapeutic_target_for	disease	0.90
Glymphatic Function	activates	phenotype	0.70

Incoming (0)

Source	Relation	Type	Str
No incoming edges

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (2)

Scientific analyses that reference this entity

Orexin-A manipulation in AD cognition and circadian dysfunction

neurodegeneration | 2026-04-26 | 3 hypotheses Top: 0.758

What is the therapeutic window between tau propagation inhibition and essential

neurodegeneration | 2026-04-06 | 5 hypotheses Top: 0.780

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (2)

Multi-agent debates referencing this entity

Does manipulating orexin-A directly rescue cognitive deficits and circadian dysf

closed · Rounds: 4 · Score: 0.78 · 2026-04-26

The debate highlighted that most promising targets (VAMP2, ESCRT, fascin-1) are

closed · Rounds: 4 · Score: 0.75 · 2026-04-22

Related Research

Hypotheses and analyses mentioning orexin receptor antagonists in their description or question text

No additional research found